Sponsor Pipeline

Peter Siesjö Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
1
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05669820 Antisecretory Factor Glioblastoma Phase 2 Glioblastoma Recruiting
Phase 2
NCT06710249 Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema Glioblastoma Recruiting
NCT04117672 Antisecretory Factor In Severe Traumatic Brain Injury Traumatic Brain Injury Recruiting
NCT07364786 Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma Glioblastoma Recruiting
Disease Areas
Glioblastoma (3)
Get alerts when Peter Siesjö's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free